V12-12 ROBOTIC METASTATECTOMY WITH EXTRACTION INCISION AND NATURAL ORIFICE INTRAOPERATIVE RADIATION THERAPY

Abstract

You have accessJournal of UrologyBladder Cancer & Urinary Diversion (V12)1 Apr 2020V12-12 ROBOTIC METASTATECTOMY WITH EXTRACTION INCISION AND NATURAL ORIFICE INTRAOPERATIVE RADIATION THERAPY Ahmad Shabsigh* Ahmad Shabsigh*Ahmad Shabsigh* More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000957.012AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Open excision of intra-abdominal recurrent malignancies with intraoperative radiation therapy (IORT) is usually a complex and morbid procedure. The objective of this video is to report the outcome of our early experience in robotic excision of abdominal localized malignant recurrences with IORT. METHODS: Retrospective analysis of 4 consecutive patients who underwent robotic resection of localized intra-abdominal malignant recurrences and IORT at a single institution between 2015 and 2018. Wide robotic excision was performed in standard fashion. Three patients underwent IOPRT using a cone inserted through a small extraction incision and the female patient had transvaginal IORT. Intraoperative and postoperative outcomes were assessed. Peri/postoperative complications were reported according Clavien-Dindo classification system. RESULTS: 3 male patients with history of recurrent rectal cancer in the pelvis and one female patient with recurrent urethral adenocarcinoma were included. Complete resection was achieved for all patients. Average estimated blood loss was minimal. No patients needed IV narcotics. One patient developed postoperative ileus and significant prolonged pubic bone pain after discharge that eventually resolved. Average hospitalization was 1.3 days compared to 7.4 days for open surgery. 75% of patients had local disease control for at least 1 year after surgery. CONCLUSIONS: Robotic excision of localized recurrent malignant neoplasms with IORT is feasible, safe and may offer better outcomes. Experienced robotic urologic oncologists are essential to develop these multidisciplinary programs Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1114-e1114 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ahmad Shabsigh* More articles by this author Expand All Advertisement PDF downloadLoading ...